EVs of specific cells, organs, diseases, and organisms: EVs in infectious diseases and vaccines

OT11.1 - Unbiased quantitative proteomic analysis identifies novel cellular components specifically incorporated into endogenous EV subtypes, HIV-1 particles and virus-modified EVs

Co-Author(s)

• 

  lorena Martin-Jaular

  posdoct
  INSERM U932, Institut Curie, PSL Research university

  Slides and Audio
• NN

  Nathalie Nevo

  INSERM U932, Institut Curie, PSL Research university
• mt

  mercedes tkach

  INSERM U932, Institut Curie, PSL Research university
• mj

  mabel jouve

  CNRS UMR3215, Institut Curie, PSL Research university
• FD

  Florent Dingli

  Institut Curie, PSL Research University, Laboratoire de Spectrométrie de Masse Protéomique
• dl

  damarys loew

  Institut Curie, PSL Research University, Laboratoire de Spectrométrie de Masse Protéomique
• KW

  Kenneth Witwer

  Department of Molecular and Comparative Pathobiology and Department of Neurology, The Johns Hopkins University School of Medicine
• mo

  matias ostrowski

  Instituto INBIRS, Universidad de Buenos Aires-CONICET
• gb

  georg borner

  Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry,

Last Author (Senior or Lead Researcher on the abst(s)

• 

  Clotilde Théry, MD PhD

  Research Director
  INSERM U932, Institut Curie, PSL Research university

Presenting Author(s)

• 

  lorena Martin-Jaular

  posdoct
  INSERM U932, Institut Curie, PSL Research university

  Slides and Audio